Farzin Beygui
Impact in
- Internal Medicine top 0.1%
- Venous Thromboembolism Diagnosis and Management
-
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Cardiac Valve Diseases and Treatments
Papers in
-
- Antiplatelet Therapy and Cardiovascular Diseases 63
- Acute Myocardial Infarction Research 47
- Cardiac Valve Diseases and Treatments 15
- Atrial Fibrillation Management and Outcomes 8
- Surgery 49
- Coronary Interventions and Diagnostics 42
- Co-authors
- Gilles Montalescot (73 shared papers)Jean‐Philippe Collet (42 shared papers)Johanne Silvain (39 shared papers)Olivier Barthélémy (37 shared papers)Guillaume Cayla (26 shared papers)Anne Bellemain-Appaix (23 shared papers)Jean‐Sébastien Hulot (10 shared papers)Ana Peña (11 shared papers)
- Journals
- European Heart Journal (17 papers)Journal of the American College of Cardiology (16 papers)Circulation (11 papers)Archives of cardiovascular diseases (11 papers)International Journal of Cardiology (9 papers)
- Partner nations
- FranceUnited StatesNetherlands
In The Last Decade
Farzin Beygui
207 papers receiving 20.2k citations
Farzin Beygui's Hit Papers
Peers
Comparison fields: 5 of 128
- Internal Medicine 2.7k
- Cardiology and Cardiovascular Medicine 10.1k
- Emergency Medicine 1.1k
- Surgery 4.8k
- Radiology, Nuclear Medicine and Imaging 1.1k
Countries citing papers authored by Farzin Beygui
This map shows the geographic impact of Farzin Beygui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farzin Beygui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farzin Beygui more than expected).
Fields of papers citing papers by Farzin Beygui
This network shows the impact of papers produced by Farzin Beygui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farzin Beygui. The network helps show where Farzin Beygui may publish in the future.
Co-authors
The 25 scholars most cited alongside Farzin Beygui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 218 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 ESC/EACTS Guidelines on myocardial revascularization Hit paper breakdown → | 2014 | 3533 |
| 2 | 2014 ESC/EACTS Guidelines on myocardial revascularization Hit paper breakdown → | 2014 | 3485 |
| 3 | 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) Hit paper breakdown → | 2019 | 3253 |
| 4 | Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study Hit paper breakdown → | 2008 | 773 |
| 5 | Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting Hit paper breakdown → | 2012 | 730 |
| 6 | European Resuscitation Council Guidelines for Resuscitation 2015 Hit paper breakdown → | 2015 | 691 |
| 7 | Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial Hit paper breakdown → | 2018 | 612 |
| 8 | 2010 | 454 | |
| 9 | 2006 | 431 | |
| 10 | 2011 | 322 | |
| 11 | Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial Hit paper breakdown → | 2016 | 317 |
| 12 | 2010 | 314 | |
| 13 | 2017 | 301 | |
| 14 | 2004 | 268 | |
| 15 | 2014 | 242 | |
| 16 | 2009 | 234 | |
| 17 | 2018 | 175 | |
| 18 | 2011 | 168 | |
| 19 | 2012 | 162 | |
| 20 | 2012 | 152 |
About Farzin Beygui
Farzin Beygui is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Emergency Medicine, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 218 papers that have together received 21.2k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (63 papers), Acute Myocardial Infarction Research (47 papers), Coronary Interventions and Diagnostics (42 papers), Cardiac Valve Diseases and Treatments (15 papers), Cardiac Imaging and Diagnostics (13 papers), Cardiac Arrest and Resuscitation (9 papers), Atrial Fibrillation Management and Outcomes (8 papers) and Hormonal Regulation and Hypertension (8 papers). The work is most often cited by research in Internal Medicine (2.7k citations), Cardiology and Cardiovascular Medicine (10.1k citations), Emergency Medicine (1.1k citations), Surgery (4.8k citations) and Radiology, Nuclear Medicine and Imaging (1.1k citations). Farzin Beygui has collaborated with scholars based in France, United States and Netherlands. Frequent co-authors include Gilles Montalescot, Jean‐Philippe Collet, Johanne Silvain, Olivier Barthélémy, Guillaume Cayla, Anne Bellemain-Appaix, Jean‐Sébastien Hulot, Ana Peña, Laurent Payot and Delphine Brugier. Their work appears in journals such as European Heart Journal, Journal of the American College of Cardiology, Circulation, Archives of cardiovascular diseases and International Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.